Dr. Peter McSweeney, MD
Claim this profileColorado Blood Cancer Institute
Studies Lymphoma
Studies Multiple Myeloma
6 reported clinical trials
9 drugs studied
Area of expertise
1Lymphoma
Stage IV
Philadelphia chromosome positive
CD19 positive
2Multiple Myeloma
Stage IV
Affiliated Hospitals
Clinical Trials Peter McSweeney, MD is currently running
CAR NK Cells
for B-Cell Cancers
This is a single arm, open-label, multi-center, Phase 1 study to determine the safety and tolerability of an experimental therapy called NKX019 (allogeneic CAR NK cells targeting CD19) in patients with relapsed/refractory non-Hodgkin lymphoma (NHL), chronic lymphocytic leukemia (CLL) or B cell acute lymphoblastic leukemia (B-ALL)
Recruiting1 award Phase 114 criteria
Unlicensed Cord Blood Transplant
for Blood/Immune System Disorders
This trial is testing the safety of giving patients special blood from umbilical cords. The study focuses on patients who receive these infusions to see if there are any serious side effects. The cord blood has special cells that can help make new blood cells in the body. Umbilical cord blood has been used in the treatment of various diseases for many years, including leukemia, lymphoma, and congenital immunodeficiency.
Recruiting1 award Phase 21 criteria
More about Peter McSweeney, MD
Clinical Trial Related6 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Peter McSweeney, MD has experience with
- Elotuzumab
- Dexamethasone
- Pomalidomide
- NKX019
- Tacrolimus
- MMF
Breakdown of trials Peter McSweeney, MD has run
Lymphoma
Multiple Myeloma
Leukemia
Non-Hodgkin's Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Peter McSweeney, MD specialize in?
Peter McSweeney, MD focuses on Lymphoma and Multiple Myeloma. In particular, much of their work with Lymphoma has involved Stage IV patients, or patients who are Philadelphia chromosome positive.
Is Peter McSweeney, MD currently recruiting for clinical trials?
Yes, Peter McSweeney, MD is currently recruiting for 2 clinical trials in Denver Colorado. If you're interested in participating, you should apply.
Are there any treatments that Peter McSweeney, MD has studied deeply?
Yes, Peter McSweeney, MD has studied treatments such as Elotuzumab, Dexamethasone, Pomalidomide.
What is the best way to schedule an appointment with Peter McSweeney, MD?
Apply for one of the trials that Peter McSweeney, MD is conducting.
What is the office address of Peter McSweeney, MD?
The office of Peter McSweeney, MD is located at: Colorado Blood Cancer Institute, Denver, Colorado 80218 United States. This is the address for their practice at the Colorado Blood Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.